During the past decade, Centre for Pediatric Rheumatology, Klinikum Eilbek conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre for Pediatric Rheumatology, Klinikum Eilbek" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Gabriela Riemekasten" with 1 trials sponsored, "Gabriele Valentini" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Pediatric Rheumatology, Klinikum Eilbek" #1 collaborator was "Charite University, Berlin, Germany" with 5 trials as a collaborator, "European Union" with 5 trials as a collaborator, "Schoen Klinik Hamburg Eilbek" with 5 trials as a collaborator, "University College, London" with 5 trials as a collaborator and "University of Basel" with 5 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Pediatric Rheumatology, Klinikum Eilbek" are "Systemic Sclerosis" (5 trials), "Arthritis" (1 trials), "Cardiac Arrhythmia" (1 trials), "Cardiac Diseases" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Centre for Pediatric Rheumatology, Klinikum Eilbek" in a lesser frequency.

Most popular intervention types in "Centre for Pediatric Rheumatology, Klinikum Eilbek" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "Baricitinib" (1 trials), "Nintedanib (Ofev®)" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Pediatric Rheumatology, Klinikum Eilbek" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Centre for Pediatric Rheumatology, Klinikum Eilbek". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centre for Pediatric Rheumatology, Klinikum Eilbek, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Pediatric Rheumatology, Klinikum Eilbek, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".